IPG Photonics CorporationRevenue up 11%, EPS $0.58, and acquisition expected accretive.
IPG Photonics reported second-quarter revenue of $279 million, an 11% increase from a year earlier and its third consecutive quarter of double-digit year-over-year sales growth. Industrial solutions revenue rose 16% year over year, led by battery-welding applications, while advanced solutions revenue declined 9% year over year but grew 10% sequentially on semiconductor demand tied to AI-related GPUs and high-bandwidth memory. The company agreed to acquire Lumibird Medical, a deal expected to expand its medical addressable market by about $1 billion and be accretive to gross margin, EBITDA, and adjusted earnings per share in its first year. Adjusted gross margin was 40.7%, adjusted diluted earnings per share were $0.58, and the company ended the quarter with $904 million in cash and investments and no debt. For the third quarter, IPG forecast revenue of $265 million to $295 million and adjusted diluted earnings per share of $0.30 to $0.60, including an estimated 150-basis-point tariff impact on adjusted gross margin.
IPG Photonics CorporationRevenue up 11%, EPS $0.58, and acquisition expected accretive.
Lumibird SAAcquired by IPG, expanding medical market and expected to be accretive.